董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Timothy Herbert | 男 | Chief Executive Officer, President and Chairman of the Board | 62 | 486.56万美元 | 未持股 | 2026-01-30 |
| Casey Tansey | 男 | Independent Director | 67 | 15.00万美元 | 未持股 | 2026-01-30 |
| Georgia Garinois Melenikiotou | 女 | Independent Director | 65 | 18.42万美元 | 未持股 | 2026-01-30 |
| Shelley Broader | 女 | Independent Director | 60 | 17.29万美元 | 未持股 | 2026-01-30 |
| Cynthia B. Burks | -- | Independent Director | -- | 未披露 | 未持股 | 2026-01-30 |
| Myriam J. Curet | -- | Independent Director | -- | 未披露 | 未持股 | 2026-01-30 |
| Gary L. Ellis | 男 | Lead Independent Director | 68 | 15.00万美元 | 未持股 | 2026-01-30 |
| Shawn T McCormick | 男 | Independent Director | 60 | 15.00万美元 | 未持股 | 2026-01-30 |
| Dana G. Mead, Jr. | 男 | Independent Director | 66 | 15.00万美元 | 未持股 | 2026-01-30 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Timothy Herbert | 男 | Chief Executive Officer, President and Chairman of the Board | 62 | 486.56万美元 | 未持股 | 2026-01-30 |
| Melissa Mann | -- | Chief People Officer | -- | 未披露 | 未持股 | 2026-01-30 |
| John C. Rondoni | -- | Chief Technology Officer | -- | 未披露 | 未持股 | 2026-01-30 |
| Jason P. Kelly | -- | Chief Manufacturing Officer and Chief Quality Officer | -- | 未披露 | 未持股 | 2026-01-30 |
| Carlton W. Weatherby | -- | Chief Strategy Officer and Chief Growth Officer | -- | 未披露 | 未持股 | 2026-01-30 |
| Bryan K. Phillips | 男 | Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 54 | 未披露 | 未持股 | 2026-01-30 |
董事简历
中英对照 | 中文 | 英文- Timothy Herbert
-
Timothy Herbert，我们的创始人，自2007年11月以来一直担任我们的首席执行官兼总裁，并担任我们的董事会成员。在加入我们之前，赫伯特先生在Medtronic公司工作了11年，这是一家医疗设备开发公司，他在该公司担任过产品开发、临床研究、销售、营销和梦百合报销方面的管理职务。Herbert先生拥有北达科他州立大学（North Dakota State University）的电气工程学士学位和圣托马斯大学（University of St.Thomas）的工商管理硕士学位。
Timothy Herbert,has served as Chief Executive Officer and President and as a member of Board since November 2007. Prior to joining, Mr. Herbert spent 11 years at Medtronic, a medical equipment development company, where he held management positions in product development, clinical research, sales, marketing, and healthcare reimbursement. Mr. Herbert holds a B.S. in electrical engineering from North Dakota State University and an M.B.A. from the University of St. Thomas. - Timothy Herbert，我们的创始人，自2007年11月以来一直担任我们的首席执行官兼总裁，并担任我们的董事会成员。在加入我们之前，赫伯特先生在Medtronic公司工作了11年，这是一家医疗设备开发公司，他在该公司担任过产品开发、临床研究、销售、营销和梦百合报销方面的管理职务。Herbert先生拥有北达科他州立大学（North Dakota State University）的电气工程学士学位和圣托马斯大学（University of St.Thomas）的工商管理硕士学位。
- Timothy Herbert,has served as Chief Executive Officer and President and as a member of Board since November 2007. Prior to joining, Mr. Herbert spent 11 years at Medtronic, a medical equipment development company, where he held management positions in product development, clinical research, sales, marketing, and healthcare reimbursement. Mr. Herbert holds a B.S. in electrical engineering from North Dakota State University and an M.B.A. from the University of St. Thomas.
- Casey Tansey
-
Casey Tansey自2008年1月以来一直担任我们的董事会成员。Tansey先生自2014年8月起担任风险投资公司U.S.Venture Partners“；USVP”；的管理合伙人，并于2005年4月至2014年7月担任USVP的管理成员。Tansey先生曾于2006年至2017年担任IntersectEnt，Inc.董事会成员，并于2008年10月至2017年10月担任ReShape Medical，Inc.董事会成员。Tansey先生拥有圣母学院（College of Notre Dame）的学士学位和工商管理硕士学位。
Casey Tansey,has served on Shoulder Innovations board of directors since October 2020. Since 2014, Mr. Tansey has served as the Managing Partner of USVP Management Company. Mr. Tansey has been a member of the board of directors of Inspire Medical Systems, Inc.(NYSE: INSP) since 2007 and of UCSF MTVP Investment Advisory since 2017. He has also served on the boards of several other medical technology and healthcare-related companies, including Cagent Vascular, HeartFlow, Inc., Highlife Medical, Inc., Luminopia, Inc., MicroTransponder, Inc., Neuros Medical, NeoChord, Inc., and ShiraTronics. He received a B.S. in Business and a M.B.A. in Business from the College of Notre Dame. - Casey Tansey自2008年1月以来一直担任我们的董事会成员。Tansey先生自2014年8月起担任风险投资公司U.S.Venture Partners“；USVP”；的管理合伙人，并于2005年4月至2014年7月担任USVP的管理成员。Tansey先生曾于2006年至2017年担任IntersectEnt，Inc.董事会成员，并于2008年10月至2017年10月担任ReShape Medical，Inc.董事会成员。Tansey先生拥有圣母学院（College of Notre Dame）的学士学位和工商管理硕士学位。
- Casey Tansey,has served on Shoulder Innovations board of directors since October 2020. Since 2014, Mr. Tansey has served as the Managing Partner of USVP Management Company. Mr. Tansey has been a member of the board of directors of Inspire Medical Systems, Inc.(NYSE: INSP) since 2007 and of UCSF MTVP Investment Advisory since 2017. He has also served on the boards of several other medical technology and healthcare-related companies, including Cagent Vascular, HeartFlow, Inc., Highlife Medical, Inc., Luminopia, Inc., MicroTransponder, Inc., Neuros Medical, NeoChord, Inc., and ShiraTronics. He received a B.S. in Business and a M.B.A. in Business from the College of Notre Dame.
- Georgia Garinois Melenikiotou
-
Georgia Garinois Melenikiotou自2020年7月起担任我们的董事会成员。Garinois-Melenikiotou女士曾于2015年1月至2020年7月担任全球美容产品公司EST&233；E Lauder Companies&8221；的企业营销部执行Vice President，并于2010年至2014年12月担任ELC&8217；S的企业营销部高级副总裁，。在加入ELC之前，Garinois-Melenikiotou在强生公司拥有27年的职业生涯，该公司是一家医疗器械、医药产品和包装消费品的全球制造商，包括几个高级领导职位，最近的职位是从2007年到2010年担任美容全球业务部门战略和新增长部总裁，在此之前，从2006年到2007年，担任EAME美容护理总裁。除了担任我们的董事会成员外，Garinois-Melenikiotou女士自2015年起担任西班牙制药公司Almirall，S.A.的董事会成员，自2020年9月起担任医疗技术公司Pulmonx Corporation的董事会成员。Garinois-Melenikiotou女士拥有雅典国立技术大学工程学学士学位和硕士学位，以及M.I.T.斯隆管理学院工商管理硕士学位。
Georgia Garinois Melenikiotou,served as Executive Vice President, Corporate Marketing at The Estée Lauder Companies, a global beauty products company, from January 2015 to July 2020, and as Senior Vice President, Corporate Marketing from April 2010 through December 2014. Prior to The Estée Lauder Companies, Ms. Garinois-Melenikiotou spent 27-years at Johnson & Johnson, a global manufacturer of medical devices, pharmaceutical products and consumer packaged goods, including in several senior leadership positions, most recently as President, Beauty Global Business Unit Strategy and New Growth from 2007 to 2010 and, from 2006 to 2007, as President, Beauty Care, EAME. Ms. Garinois-Melenikiotou currently serves on the boards of directors of Douglas Group, a European beauty products retailer, since March 2024, and Inspire Medical Systems, a medical device company, since July 2020. She has also served on the board of directors of Almirall, S.A. from June 2016 to June 2022 and the board of directors of Natura & Co Holding S.A. from April 2021 to September 2024. Additionally, Ms. Garinois-Melenikiotou serves on the board of directors of the Sloan School of Management at M.I.T. Ms. Garinois-Melenikiotou holds a B.S. and an M.S. in Engineering from the National Technical University of Athens and an M.B.A. from the Sloan School of Management at M.I.T. - Georgia Garinois Melenikiotou自2020年7月起担任我们的董事会成员。Garinois-Melenikiotou女士曾于2015年1月至2020年7月担任全球美容产品公司EST&233；E Lauder Companies&8221；的企业营销部执行Vice President，并于2010年至2014年12月担任ELC&8217；S的企业营销部高级副总裁，。在加入ELC之前，Garinois-Melenikiotou在强生公司拥有27年的职业生涯，该公司是一家医疗器械、医药产品和包装消费品的全球制造商，包括几个高级领导职位，最近的职位是从2007年到2010年担任美容全球业务部门战略和新增长部总裁，在此之前，从2006年到2007年，担任EAME美容护理总裁。除了担任我们的董事会成员外，Garinois-Melenikiotou女士自2015年起担任西班牙制药公司Almirall，S.A.的董事会成员，自2020年9月起担任医疗技术公司Pulmonx Corporation的董事会成员。Garinois-Melenikiotou女士拥有雅典国立技术大学工程学学士学位和硕士学位，以及M.I.T.斯隆管理学院工商管理硕士学位。
- Georgia Garinois Melenikiotou,served as Executive Vice President, Corporate Marketing at The Estée Lauder Companies, a global beauty products company, from January 2015 to July 2020, and as Senior Vice President, Corporate Marketing from April 2010 through December 2014. Prior to The Estée Lauder Companies, Ms. Garinois-Melenikiotou spent 27-years at Johnson & Johnson, a global manufacturer of medical devices, pharmaceutical products and consumer packaged goods, including in several senior leadership positions, most recently as President, Beauty Global Business Unit Strategy and New Growth from 2007 to 2010 and, from 2006 to 2007, as President, Beauty Care, EAME. Ms. Garinois-Melenikiotou currently serves on the boards of directors of Douglas Group, a European beauty products retailer, since March 2024, and Inspire Medical Systems, a medical device company, since July 2020. She has also served on the board of directors of Almirall, S.A. from June 2016 to June 2022 and the board of directors of Natura & Co Holding S.A. from April 2021 to September 2024. Additionally, Ms. Garinois-Melenikiotou serves on the board of directors of the Sloan School of Management at M.I.T. Ms. Garinois-Melenikiotou holds a B.S. and an M.S. in Engineering from the National Technical University of Athens and an M.B.A. from the Sloan School of Management at M.I.T.
- Shelley Broader
-
Shelley Broader自2020年10月起担任我们的董事会成员。Broader女士于2015年12月至2019年4月担任时尚零售商Chico’；s FAS，Inc.的首席执行官兼总裁。在此之前，布罗德曾于2009年至2015年11月在跨国零售公司沃尔玛（沃尔玛公司）担任多个高管职位，包括沃尔玛欧洲（Walmart Europe）总裁兼首席执行官，2014年7月至2015年10月，担任Walmart Canada Corp.的总裁兼首席执行官；2011年9月至2014年5月，担任Walmart Canada Corp.的首席营销官；2009年至2010年，担任沃尔玛（Walmart）旗下Sam&；8217；s Club A分部的高级副总裁。布罗德女士此前曾于2015年12月至2019年4月担任Chico’；s FAS，Inc.的董事会成员，并于2008年2月至2020年2月担任Raymond JamesFinancial，Inc.的董事会成员。Broader女士是莫菲特癌症中心（Moffitt Cancer Center&8217；s National Advisors）的董事会成员。Broader女士拥有华盛顿州立大学（Washington State University）的学士学位。
Shelley Broader has served as a member of board of directors since August 2021. Ms. Broader served as Chief Executive Officer and President of Chico's FAS, Inc., a fashion retailer, from December 2015 to April 2019. Prior to this, Ms. Broader served as Executive Vice President at Walmart Inc. NYSE: WMT, a multinational retail company, from 2009 to November 2015 in various executive roles, including as President and Chief Executive Officer of the Walmart Europe, Middle East and Sub-Saharan Africa region from July 2014 to October 2015 President and Chief Executive Officer of Walmart Canada Corp. from September 2011 to May 2014 Chief Merchandising Officer of Walmart Canada Corp. from 2010 to 2011 and Senior Vice President for Sam's Club (a division of Walmart) from 2009 to 2010. Ms. Broader previously served on the board of directors of Chico's FAS, Inc. (NYSE: CHS) from December 2015 to April 2019 and Raymond James Financial, Inc. from February 2008 to February 2020. Ms. Broader is a member of the board of directors of Inspire Medical Systems, Inc. (NYSE:INSP), IFCO Systems and the Moffitt Cancer Center's National Board of Advisors. Ms. Broader holds a B.A. from Washington State University. - Shelley Broader自2020年10月起担任我们的董事会成员。Broader女士于2015年12月至2019年4月担任时尚零售商Chico’；s FAS，Inc.的首席执行官兼总裁。在此之前，布罗德曾于2009年至2015年11月在跨国零售公司沃尔玛（沃尔玛公司）担任多个高管职位，包括沃尔玛欧洲（Walmart Europe）总裁兼首席执行官，2014年7月至2015年10月，担任Walmart Canada Corp.的总裁兼首席执行官；2011年9月至2014年5月，担任Walmart Canada Corp.的首席营销官；2009年至2010年，担任沃尔玛（Walmart）旗下Sam&；8217；s Club A分部的高级副总裁。布罗德女士此前曾于2015年12月至2019年4月担任Chico’；s FAS，Inc.的董事会成员，并于2008年2月至2020年2月担任Raymond JamesFinancial，Inc.的董事会成员。Broader女士是莫菲特癌症中心（Moffitt Cancer Center&8217；s National Advisors）的董事会成员。Broader女士拥有华盛顿州立大学（Washington State University）的学士学位。
- Shelley Broader has served as a member of board of directors since August 2021. Ms. Broader served as Chief Executive Officer and President of Chico's FAS, Inc., a fashion retailer, from December 2015 to April 2019. Prior to this, Ms. Broader served as Executive Vice President at Walmart Inc. NYSE: WMT, a multinational retail company, from 2009 to November 2015 in various executive roles, including as President and Chief Executive Officer of the Walmart Europe, Middle East and Sub-Saharan Africa region from July 2014 to October 2015 President and Chief Executive Officer of Walmart Canada Corp. from September 2011 to May 2014 Chief Merchandising Officer of Walmart Canada Corp. from 2010 to 2011 and Senior Vice President for Sam's Club (a division of Walmart) from 2009 to 2010. Ms. Broader previously served on the board of directors of Chico's FAS, Inc. (NYSE: CHS) from December 2015 to April 2019 and Raymond James Financial, Inc. from February 2008 to February 2020. Ms. Broader is a member of the board of directors of Inspire Medical Systems, Inc. (NYSE:INSP), IFCO Systems and the Moffitt Cancer Center's National Board of Advisors. Ms. Broader holds a B.A. from Washington State University.
- Cynthia B. Burks
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Myriam J. Curet
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Gary L. Ellis
-
Gary L. Ellis，是美敦力公司的高级副总裁兼首席财务官，这是一家位于明尼苏达州明尼阿波利斯的全球医疗技术公司。自2005年5月以来，他一直曾担任这些职务。此前，从1999年至2005年5月，他是美敦力公司的副总裁、公司主管及财务总监。在2006年，他首次当选为托罗董事会。他是财务委员会的主席和审计委员会的成员。他任职于美国明尼苏达科学博物馆和大双城联合劝募组织的董事。
Gary L. Ellis,retired from Medtronic plc, Dublin, Ireland (a global medical technology company). He held the following positions, all at Medtronic:Executive Vice President, Global Operations, Information Technology and Facilities & Real Estate (June 2016 – December 2016).Executive Vice President and Chief Financial Officer (April 2014 – June 2016).Senior Vice President and Chief Financial Officer (May 2005 – April 2014).Vice President, Corporate Controller and Treasurer (October 1999 – May 2005). - Gary L. Ellis，是美敦力公司的高级副总裁兼首席财务官，这是一家位于明尼苏达州明尼阿波利斯的全球医疗技术公司。自2005年5月以来，他一直曾担任这些职务。此前，从1999年至2005年5月，他是美敦力公司的副总裁、公司主管及财务总监。在2006年，他首次当选为托罗董事会。他是财务委员会的主席和审计委员会的成员。他任职于美国明尼苏达科学博物馆和大双城联合劝募组织的董事。
- Gary L. Ellis,retired from Medtronic plc, Dublin, Ireland (a global medical technology company). He held the following positions, all at Medtronic:Executive Vice President, Global Operations, Information Technology and Facilities & Real Estate (June 2016 – December 2016).Executive Vice President and Chief Financial Officer (April 2014 – June 2016).Senior Vice President and Chief Financial Officer (May 2005 – April 2014).Vice President, Corporate Controller and Treasurer (October 1999 – May 2005).
- Shawn T McCormick
-
Shawn T McCormick，2012年9月加入本公司，担任首席财务官。加入本公司之前，2011年4月至2012年2月，他担任Lutonix的首席运营官，这是一个医疗器械公司，在2011年12月被C. R. Bard收购。2009年1月至2010年7月，他担任ev3 Inc.的高级副总裁、首席财务官，这是一个全球性的血管内装置公司，在2010年7月被Covidien plc收购。加入ev3之前，他是全球性医疗器械公司Medtronic的企业发展副总裁，负责该公司的全球业务开发工作。他于1992年加入Medtronic，任期内担任过各种财务和领导职位。2007年7月至2008年5月，他担任Medtronic的企业技术与新创企业部副总裁。2002年7月至2007年7月，他担任Medtronic脊髓、生物制剂与导航业务的财务副总裁。此前，他还担任过该公司的其它职务，包括企业发展总监、首席企业发展助理、经理、财务分析、高级财务分析师，及高级审计师。加入Medtronic之前，他在会计师事务所KPMG Peat Marwick工作了4年。他在University of Minnesota's Carlson School of Management获得工商管理硕士学位，在Arizona State University获得会计学士学位。他是注册会计师。
Shawn T McCormick since November 2020 Mr. McCormick has served as Chief Financial Officer of Aldevron, LLC, a technology company specializing in the manufacture of plasmid DNA, mRNA and proteins. Before Aldevron, Mr. McCormick served as Chief Financial Officer of Tornier N.V., a global orthopedic company, from September 2012 until October 2015 when Tornier merged with Wright Medical Group, Inc. Before Tornier, Mr. McCormick served as Chief Operating Officer of Lutonix, Inc., a medical device company, from April 2011 to February 2012 and as Chief Financial Officer and Senior Vice President of ev3 Inc., a global endovascular company, from January 2009 to July 2010 when ev3 was acquired by Covidien plc. From 1992 to 2009 Mr. McCormick held various positions at Medtronic, including as its Vice President, Corporate Development, where he was responsible for leading Medtronic's worldwide business development activities and VP Finance for the Spinal, Biologics and Navigation business.Mr. McCormick also served on the board of directors of Entellus Medical, Inc. from 2014 to February 2018 and Surmodics, Inc. from 2015 to December 2020. Mr. McCormick holds a B.S. in Accounting from Arizona State University and an M.B.A. from the University of Minnesota's Carlson School of Management and is a certified public accountant inactive. He is also a National Association of Corporate Directors Fellow. - Shawn T McCormick，2012年9月加入本公司，担任首席财务官。加入本公司之前，2011年4月至2012年2月，他担任Lutonix的首席运营官，这是一个医疗器械公司，在2011年12月被C. R. Bard收购。2009年1月至2010年7月，他担任ev3 Inc.的高级副总裁、首席财务官，这是一个全球性的血管内装置公司，在2010年7月被Covidien plc收购。加入ev3之前，他是全球性医疗器械公司Medtronic的企业发展副总裁，负责该公司的全球业务开发工作。他于1992年加入Medtronic，任期内担任过各种财务和领导职位。2007年7月至2008年5月，他担任Medtronic的企业技术与新创企业部副总裁。2002年7月至2007年7月，他担任Medtronic脊髓、生物制剂与导航业务的财务副总裁。此前，他还担任过该公司的其它职务，包括企业发展总监、首席企业发展助理、经理、财务分析、高级财务分析师，及高级审计师。加入Medtronic之前，他在会计师事务所KPMG Peat Marwick工作了4年。他在University of Minnesota's Carlson School of Management获得工商管理硕士学位，在Arizona State University获得会计学士学位。他是注册会计师。
- Shawn T McCormick since November 2020 Mr. McCormick has served as Chief Financial Officer of Aldevron, LLC, a technology company specializing in the manufacture of plasmid DNA, mRNA and proteins. Before Aldevron, Mr. McCormick served as Chief Financial Officer of Tornier N.V., a global orthopedic company, from September 2012 until October 2015 when Tornier merged with Wright Medical Group, Inc. Before Tornier, Mr. McCormick served as Chief Operating Officer of Lutonix, Inc., a medical device company, from April 2011 to February 2012 and as Chief Financial Officer and Senior Vice President of ev3 Inc., a global endovascular company, from January 2009 to July 2010 when ev3 was acquired by Covidien plc. From 1992 to 2009 Mr. McCormick held various positions at Medtronic, including as its Vice President, Corporate Development, where he was responsible for leading Medtronic's worldwide business development activities and VP Finance for the Spinal, Biologics and Navigation business.Mr. McCormick also served on the board of directors of Entellus Medical, Inc. from 2014 to February 2018 and Surmodics, Inc. from 2015 to December 2020. Mr. McCormick holds a B.S. in Accounting from Arizona State University and an M.B.A. from the University of Minnesota's Carlson School of Management and is a certified public accountant inactive. He is also a National Association of Corporate Directors Fellow.
- Dana G. Mead, Jr.
-
Dana G. Mead, Jr.，自2008年7月起担任董事会成员。Mead先生于2019年5月至2021年2月担任HeartFlow，Inc.的首席执行官兼总裁，HeartFlow，Inc.是一家改变心脏病诊断和治疗方式的数字健康公司。2016年至2019年5月，Mead先生担任Beaver-Visitec International，Inc.的首席执行官兼总裁，Beaver-Visitec International，Inc.是一家外科手术设备开发商和制造商。从2005年到2016年，Mead先生在风险投资公司Kleiner Perkins Caufield & Byers担任合伙人。除了在董事会任职外，Mead先生自2015年6月起担任医疗技术公司Intersect ENT，Inc.的董事会成员，自2008年起担任Pulmonx Corporation的董事会成员。2011年5月至2016年12月，Mead先生在远程健康公司Teladoc, Inc.的董事会任职。Mead先生拥有拉法叶学院的学士学位和南加州大学的工商管理硕士学位。
Dana G. Mead, Jr.,served as the Chief Executive Officer, President and director of HeartFlow, Inc., a medical technology company. From November 2016 to May 2019, Mr. Mead served as President and Chief Executive Officer of Beaver-Visitec International, Inc., a surgical device developer and manufacturer. From June 2005 to November 2016, Mr. Mead served as a partner at Kleiner Perkins Caufield & Byers, a venture capital investment firm. In addition to serving on Pulmonx Corporation Board of Directors, Mr. Mead has served on the board of directors of Inari Medical, Inc. since October 2021 and the board of directors of Inspire Medical Systems since July 2008, where he serves on its audit committee. Mr. Mead also served on the board of directors of Inari Medical, Inc. from October 2021 until its sale to Stryker in February 2025 and Intersect ENT, Inc. from January 2006 until its sale to Medtronic, Inc. in May 2022. Mr. Mead holds a B.A. from Lafayette College and an M.B.A. from the University of Southern California. - Dana G. Mead, Jr.，自2008年7月起担任董事会成员。Mead先生于2019年5月至2021年2月担任HeartFlow，Inc.的首席执行官兼总裁，HeartFlow，Inc.是一家改变心脏病诊断和治疗方式的数字健康公司。2016年至2019年5月，Mead先生担任Beaver-Visitec International，Inc.的首席执行官兼总裁，Beaver-Visitec International，Inc.是一家外科手术设备开发商和制造商。从2005年到2016年，Mead先生在风险投资公司Kleiner Perkins Caufield & Byers担任合伙人。除了在董事会任职外，Mead先生自2015年6月起担任医疗技术公司Intersect ENT，Inc.的董事会成员，自2008年起担任Pulmonx Corporation的董事会成员。2011年5月至2016年12月，Mead先生在远程健康公司Teladoc, Inc.的董事会任职。Mead先生拥有拉法叶学院的学士学位和南加州大学的工商管理硕士学位。
- Dana G. Mead, Jr.,served as the Chief Executive Officer, President and director of HeartFlow, Inc., a medical technology company. From November 2016 to May 2019, Mr. Mead served as President and Chief Executive Officer of Beaver-Visitec International, Inc., a surgical device developer and manufacturer. From June 2005 to November 2016, Mr. Mead served as a partner at Kleiner Perkins Caufield & Byers, a venture capital investment firm. In addition to serving on Pulmonx Corporation Board of Directors, Mr. Mead has served on the board of directors of Inari Medical, Inc. since October 2021 and the board of directors of Inspire Medical Systems since July 2008, where he serves on its audit committee. Mr. Mead also served on the board of directors of Inari Medical, Inc. from October 2021 until its sale to Stryker in February 2025 and Intersect ENT, Inc. from January 2006 until its sale to Medtronic, Inc. in May 2022. Mr. Mead holds a B.A. from Lafayette College and an M.B.A. from the University of Southern California.
高管简历
中英对照 | 中文 | 英文- Timothy Herbert
Timothy Herbert，我们的创始人，自2007年11月以来一直担任我们的首席执行官兼总裁，并担任我们的董事会成员。在加入我们之前，赫伯特先生在Medtronic公司工作了11年，这是一家医疗设备开发公司，他在该公司担任过产品开发、临床研究、销售、营销和梦百合报销方面的管理职务。Herbert先生拥有北达科他州立大学（North Dakota State University）的电气工程学士学位和圣托马斯大学（University of St.Thomas）的工商管理硕士学位。
Timothy Herbert,has served as Chief Executive Officer and President and as a member of Board since November 2007. Prior to joining, Mr. Herbert spent 11 years at Medtronic, a medical equipment development company, where he held management positions in product development, clinical research, sales, marketing, and healthcare reimbursement. Mr. Herbert holds a B.S. in electrical engineering from North Dakota State University and an M.B.A. from the University of St. Thomas.- Timothy Herbert，我们的创始人，自2007年11月以来一直担任我们的首席执行官兼总裁，并担任我们的董事会成员。在加入我们之前，赫伯特先生在Medtronic公司工作了11年，这是一家医疗设备开发公司，他在该公司担任过产品开发、临床研究、销售、营销和梦百合报销方面的管理职务。Herbert先生拥有北达科他州立大学（North Dakota State University）的电气工程学士学位和圣托马斯大学（University of St.Thomas）的工商管理硕士学位。
- Timothy Herbert,has served as Chief Executive Officer and President and as a member of Board since November 2007. Prior to joining, Mr. Herbert spent 11 years at Medtronic, a medical equipment development company, where he held management positions in product development, clinical research, sales, marketing, and healthcare reimbursement. Mr. Herbert holds a B.S. in electrical engineering from North Dakota State University and an M.B.A. from the University of St. Thomas.
- Melissa Mann
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- John C. Rondoni
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Jason P. Kelly
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Carlton W. Weatherby
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Bryan K. Phillips
Bryan K. Phillips，自2021年1月起担任高级副总裁、总法律顾问、秘书兼首席合规官。2019年12月至2021年1月，Phillips先生担任生物制药公司Cerevel Therapeutics Holdings, Inc.的首席法务官。从2005年7月到2019年11月，Phillips先生在医疗技术公司Surmodics, Inc.担任过几个职责日益增加的职位，最近担任的职务是法律和人力资源高级副总裁、总法律顾问和秘书。此前，Phillips先生曾于2001年至2005年在Guidant Corporation的心律管理集团担任专利顾问，该集团现隶属于波士顿科学。Phillips先生的法律生涯始于一家位于明尼阿波利斯的知识产权律师事务所。Phillips先生在堪萨斯大学获得机械工程学士学位，在明尼苏达大学法学院获得法学博士学位。
Bryan K. Phillips has served as Senior Vice President, General Counsel, Secretary and Chief Compliance Officer since January 2021. From December 2019 to January 2021 Mr. Phillips served as Chief Legal Officer of Cerevel Therapeutics Holdings, Inc., a biopharmaceutical company. From July 2005 to November 2019 Mr. Phillips held several positions of increasing responsibility at Surmodics, Inc., a medical technology company, most recently as its Senior Vice President, Legal and Human Resources, General Counsel and Secretary. Previously, Mr. Phillips served as Patent Counsel at Guidant Corporation's Cardiac Rhythm Management Group now part of Boston Scientific from 2001 to 2005. Mr. Phillips began his legal career at a Minneapolis-based intellectual property law firm. Mr. Phillips earned a B.S. in mechanical engineering from the University of Kansas and a J.D. from the University of Minnesota Law School.- Bryan K. Phillips，自2021年1月起担任高级副总裁、总法律顾问、秘书兼首席合规官。2019年12月至2021年1月，Phillips先生担任生物制药公司Cerevel Therapeutics Holdings, Inc.的首席法务官。从2005年7月到2019年11月，Phillips先生在医疗技术公司Surmodics, Inc.担任过几个职责日益增加的职位，最近担任的职务是法律和人力资源高级副总裁、总法律顾问和秘书。此前，Phillips先生曾于2001年至2005年在Guidant Corporation的心律管理集团担任专利顾问，该集团现隶属于波士顿科学。Phillips先生的法律生涯始于一家位于明尼阿波利斯的知识产权律师事务所。Phillips先生在堪萨斯大学获得机械工程学士学位，在明尼苏达大学法学院获得法学博士学位。
- Bryan K. Phillips has served as Senior Vice President, General Counsel, Secretary and Chief Compliance Officer since January 2021. From December 2019 to January 2021 Mr. Phillips served as Chief Legal Officer of Cerevel Therapeutics Holdings, Inc., a biopharmaceutical company. From July 2005 to November 2019 Mr. Phillips held several positions of increasing responsibility at Surmodics, Inc., a medical technology company, most recently as its Senior Vice President, Legal and Human Resources, General Counsel and Secretary. Previously, Mr. Phillips served as Patent Counsel at Guidant Corporation's Cardiac Rhythm Management Group now part of Boston Scientific from 2001 to 2005. Mr. Phillips began his legal career at a Minneapolis-based intellectual property law firm. Mr. Phillips earned a B.S. in mechanical engineering from the University of Kansas and a J.D. from the University of Minnesota Law School.